Seeing Is Believing
Currently out of the existing stock ratings of Anupam Rama, 202 are a BUY (69.42%), 63 are a HOLD (21.65%), 26 are a SELL (8.93%).
Analyst Anupam Rama works at JPMORGAN with a stock forecast success ratio of 43.47% fulfilled within 173.62 days on average.
Anupam Rama’s has documented 563 price targets and ratings displayed on 56 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CTMX, CytomX Therapeutics at 22-Apr-2024.
Analyst best performing recommendations are on VERA (VERA THERAPEUTICS).
The best stock recommendation documented was for VERA (VERA THERAPEUTICS) at 1/22/2024. The price target of $25 was fulfilled within 3 days with a profit of $8.7 (53.37%) receiving and performance score of 177.91.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
30
$-1.67 (-5.27%)
32
2 months 3 days ago
3/3 (100%)
$-2.99 (-9.06%)
224
Hold
28
$-3.67 (-11.59%)
32
5 months 23 days ago
6/6 (100%)
$5.51 (24.50%)
192
Buy
42
$10.33 (32.62%)
67
9 months 30 days ago
5/12 (41.67%)
$13.87 (49.31%)
213
Buy
38
$6.33 (19.99%)
40
9 months 30 days ago
0/4 (0%)
$9.87 (35.09%)
Buy
37
$5.33 (16.83%)
33
1 years 8 months 21 days ago
6/11 (54.55%)
$7.26 (24.41%)
69
Which stock is Anupam Rama is most bullish on?
Which stock is Anupam Rama is most reserved on?
What Year was the first public recommendation made by Anupam Rama?